Experimental Medicine for HIV Vaccine Research and Development
Open Access
Abstract
The development of safe and effective HIV vaccines has been a scientific challenge for more than 40 years. Despite disappointing results from efficacy clinical trials, much has been learnt from years of research and development. In a rapidly evolving HIV prevention landscape, swift evaluation of multiple vaccine approaches eliciting cross-reactive humoral and cellular responses is needed to ensure the development of efficacious vaccine candidates. To contain increasing costs, innovative clinical research methods are required. Experimental medicine has the potential to accelerate vaccine discovery by iterating early stages of clinical testing faster and by selecting the most promising immunogen combinations for further clinical evaluation. As part of its mission to unite diverse stakeholders involved in the response to the HIV epidemic, the Global HIV Vaccine Enterprise at IAS—the International AIDS Society—hosted a series of online events between January and September 2022 to discuss the merits and challenges of experimental medicine studies to accelerate the development of safe and effective HIV vaccines. This report summarizes key questions and discussions across the series of events, which brought together scientists, policy makers, community stakeholders, advocates, bioethicists, and funders.Keywords
Funding Information
- Bill and Melinda Gates Foundation (INV-002054, DAA9-19-65250-1)
- National Institutes of Health (INV-002054, DAA9-19-65250-1)
This publication has 6 references indexed in Scilit:
- Vaccine Efficacy of ALVAC-HIV and Bivalent Subtype C gp120–MF59 in AdultsNew England Journal of Medicine, 2021
- Designing HIV Vaccine Efficacy Trials in the Context of Highly Effective Non-vaccine Prevention ModalitiesStatistics in Biosciences, 2020
- An HIV Vaccine Is Essential for Ending the HIV/AIDS PandemicJAMA, 2017
- Accelerating Next-Generation Vaccine Development for Global Disease PreventionScience, 2013
- Phase 0 Clinical Trials: Conceptions and MisconceptionsThe Cancer Journal, 2008
- Enhanced: The Need for a Global HIV Vaccine EnterpriseScience, 2003